Hill, N. R. et al. Global prevalence of chronic kidney disease — a systematic review and meta-analysis. PLoS One 11, e0158765 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Matsushita, K. et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat. Rev. Nephrol. 18, 696–707 (2022).

Article  PubMed  Google Scholar 

Junho, C. V. C., Frisch, J., Soppert, J., Wollenhaupt, J. & Noels, H. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Clin. Kidney J. https://doi.org/10.1093/ckj/sfad085 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Jankowski, J., Floege, J., Fliser, D., Böhm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143, 1157–1172 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noels, H. & Jankowski, J. Increased risk of cardiovascular complications in chronic kidney disease: introduction to a compendium. Circ. Res. 132, 899–901 (2023).

Article  CAS  PubMed  Google Scholar 

Cases Amenós, A., González-Juanatey, J. R., Conthe Gutiérrez, P., Matalí Gilarranz, A. & Garrido Costa, C. Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev. Esp. Cardiol. 63, 225–228 (2010).

PubMed  Google Scholar 

Wan, E. Y. F. et al. Burden of CKD and cardiovascular disease on life expectancy and health service utilization: a cohort study of Hong Kong Chinese hypertensive patients. J. Am. Soc. Nephrol. 30, 1991–1999 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zoccali, C. & Mallamaci, F. Innate immunity system in patients with cardiovascular and kidney disease. Circ. Res. 132, 915–932 (2023).

Article  CAS  PubMed  Google Scholar 

Ebert, T. et al. Inflammation and oxidative stress in chronic kidney disease and dialysis patients. Antioxid. Redox Signal. 35, 1426–1448 (2021).

Article  CAS  PubMed  Google Scholar 

Schreibing, F., Anslinger, T. M. & Kramann, R. Fibrosis in pathology of heart and kidney: from deep RNA-sequencing to novel molecular TARGets. Circ. Res. 132, 1013–1033 (2023).

Article  CAS  PubMed  Google Scholar 

Baaten, C., Vondenhoff, S. & Noels, H. Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease. Circ. Res. 132, 970–992 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hutcheson, J. D. & Goettsch, C. Cardiovascular calcification heterogeneity in chronic kidney disease. Circ. Res. 132, 993–1012 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baaten, C. et al. Platelet abnormalities in CKD and their implications for antiplatelet therapy. Clin. J. Am. Soc. Nephrol. 17, 155–170 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thakur, M. et al. NETs-induced thrombosis impacts on cardiovascular and chronic kidney disease. Circ. Res. 132, 933–949 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A. & Rodrigues-Diez, R. R. Targeting the progression of chronic kidney disease. Nat. Rev. Nephrol. 16, 269–288 (2020).

Article  PubMed  Google Scholar 

Yeung, C. K., Shen, D. D., Thummel, K. E. & Himmelfarb, J. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. Kidney Int. 85, 522–528 (2014).

Article  CAS  PubMed  Google Scholar 

Verbrugge, F. H., Tang, W. H. & Hazen, S. L. Protein carbamylation and cardiovascular disease. Kidney Int. 88, 474–478 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schunk, S. J. et al. Guanidinylated apolipoprotein C3 (ApoC3) associates with kidney and vascular injury. J. Am. Soc. Nephrol. 32, 3146–3160 (2021). This study identified guanidinylated ApoC3 and its association with declining kidney function and cardiovascular events in patients with CKD, and revealed that guanidinylated ApoC3 promoted kidney fibrosis and reduced injury-induced endothelial regeneration in animal models.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176–1184 (2007). This report identified the occurrence of protein carbamylation at sites of inflammation and atherosclerotic lesions through MPO-catalyzed oxidation of thiocyanate, and revealed that levels of carbamylated protein lysine residues predict cardiovascular event risk in individuals with largely preserved kidney function.

Article  CAS  PubMed  Google Scholar 

Delporte, C. et al. Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: a potential carbamylation route involved in the formation of atherosclerotic plaques? J. Biol. Chem. 293, 6374–6386 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berg, A. H. et al. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci. Transl. Med. 5, 175ra129 (2013).

Article  Google Scholar 

Kalim, S. et al. Protein carbamylation and the risk of ESKD in patients with CKD. J. Am. Soc. Nephrol. 34, 876–885 (2023).

Article  PubMed  Google Scholar 

Kalim, S. et al. Longitudinal changes in protein carbamylation and mortality risk after initiation of hemodialysis. Clin. J. Am. Soc. Nephrol. 11, 1809–1816 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koeth, R. A. et al. Protein carbamylation predicts mortality in ESRD. J. Am. Soc. Nephrol. 24, 853–861 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taes, Y. E. et al. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol. Dial. Transpl. 23, 1330–1335 (2008).

Article  CAS  Google Scholar 

Schuett, K. et al. Clot structure: a potent mortality risk factor in patients on hemodialysis. J. Am. Soc. Nephrol. 28, 1622–1630 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speer, T. et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity 38, 754–768 (2013).

Article  CAS  PubMed  Google Scholar 

Zewinger, S. et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur. Heart J. 38, 1597–1607 (2017). This work reported that the guanidine compound SDMA accumulated in HDL in patients with CKD, rendering HDL into a pro-inflammatory lipoprotein particle associated with increased mortality in CKD.

Article  CAS  PubMed  Google Scholar 

Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Biol. 23, 499–515 (2022).

Article  CAS  PubMed  Google Scholar 

Alhamdani, M. S., Al-Kassir, A. H., Jaleel, N. A., Hmood, A. M. & Ali, H. M. Elevated levels of alkanals, alkenals and 4-HO-alkenals in plasma of hemodialysis patients. Am. J. Nephrol. 26, 299–303 (2006).

Article  CAS  PubMed  Google Scholar 

Soulage, C. O. et al. Two toxic lipid aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), accumulate in patients with chronic kidney disease. Toxins 12, 567 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miyata, T., Kurokawa, K. & van Ypersele de Strihou, C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int. Suppl. 76, S120–S125 (2000).

Article  CAS  PubMed  Google Scholar 

Mera, K. et al. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens. Res. 28, 973–980 (2005).

Article  CAS  PubMed  Google Scholar 

Mitrogianni, Z., Barbouti, A., Galaris, D. & Siamopoulos, K. C. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin. Pract. 113, c234–c240 (2009).

Article  CAS  PubMed  Google Scholar 

Witko-Sarsat, V. et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49, 1304–1313 (1996).

Article  CAS  PubMed  Google Scholar